Licensable Technology

• New Strategy to Control Viral Infection
  The subject invention represents a novel method of controlling viral replication, especially for NNSV as well as positive-stranded RNA virus.
• Use of an Avirulent Mutant as a Live Vaccine Vector
  The subject invention is a genetically defined mutant strain of B. bronchiseptica, which is noncytotoxic in vitro and has been shown to be avirulent in vivo in mice, even in animals that are highly susceptible to Bordetellosis.
• Molecular Beacon Design to Improve Functionality in Real-Time PCR Applications
  A simple approach for modifying Molecular Beacons that improves their performance.